4//SEC Filing
Takimoto Chris H 4
Accession 0001209191-23-023703
CIK 0001496323other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 9:46 PM ET
Size
7.5 KB
Accession
0001209191-23-023703
Insider Transaction Report
Form 4
Takimoto Chris H
Chief Medical Officer
Transactions
- Award
Common Stock
2023-04-04+26,250→ 55,039 total - Award
Stock Option (right to buy)
2023-04-04+52,500→ 52,500 totalExercise: $12.86Exp: 2033-04-04→ Common Stock (52,500 underlying)
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
- [F2]1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001743780
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 9:46 PM ET
- Size
- 7.5 KB